Citation Impact
Citing Papers
A Meta-Analysis of Cytokines in Major Depression
2009 Standout
Peripheral Inflammation is Associated with Altered Substantia Nigra Activity and Psychomotor Slowing in Humans
2008
Pathobiology of tobacco smoking and neurovascular disorders: untied strings and alternative products
2015
Risk for Depression During Interferon-Alpha Treatment Is Affected by the Serotonin Transporter Polymorphism
2008
From stress to inflammation and major depressive disorder: A social signal transduction theory of depression.
2014 Standout
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
2009 Standout
What is polypharmacy? A systematic review of definitions
2017 Standout
Cascading effects of stressors and inflammatory immune system activation: implications for major depressive disorder
2009
Sleep Disturbance, Sleep Duration, and Inflammation: A Systematic Review and Meta-Analysis of Cohort Studies and Experimental Sleep Deprivation
2015 Standout
Neurovascular Unit: a Focus on Pericytes
2012
Chronic Mild Stress (CMS) Revisited: Consistency and Behavioural-Neurobiological Concordance in the Effects of CMS
2005 Standout
Adiponectin protects against cerebral ischemia–reperfusion injury through anti-inflammatory action
2009 StandoutNobel
Pericytes: Pluripotent Cells of the Blood Brain Barrier
2008
Cytokines and psychopathology: Lessons from interferon-α
2004
The Blood–Brain Barrier
2015 Standout
Cancer nanomedicine: progress, challenges and opportunities
2016 Standout
Basal Ganglia Hypermetabolism and Symptoms of Fatigue during Interferon-α Therapy
2007
Carbonic anhydrase inhibitors. Comparison of chlorthalidone, indapamide, trichloromethiazide, and furosemide X-ray crystal structures in adducts with isozyme II, when several water molecules make the difference
2008
Wernicke's encephalopathy: new clinical settings and recent advances in diagnosis and management
2007 Standout
Mechanisms of cytokine-induced behavioral changes: Psychoneuroimmunology at the translational interface
2008
TNF-alpha induced NFκB signaling and p65 (RelA) overexpression repress Cldn5 promoter in mouse brain endothelial cells
2011
Cytokines and depression
2002
Descending control of pain
2002 Standout
Carbonic anhydrase inhibitors. Interaction of indapamide and related diuretics with 12 mammalian isozymes and X-ray crystallographic studies for the indapamide–isozyme II adduct
2008
Neurotransmitter, peptide and cytokine processes in relation to depressive disorder: Comorbidity between depression and neurodegenerative disorders
2008
Albumin–drug interaction and its clinical implication
2013 Standout
Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study Of Liver Diseases and the European Association for the Study of the Liver
2014 Standout
A new blood–brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes
2008 Standout
Assessment of positive emotions in animals to improve their welfare
2007 Standout
REVIEW ON CPP: Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade
2007 Standout
CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-α: relationship to CNS immune responses and depression
2009
Cell Biology of Ischemia/Reperfusion Injury
2012 Standout
NRF2 and NF-қB interplay in cerebrovascular and neurodegenerative disorders: Molecular mechanisms and possible therapeutic approaches
2018 Standout
Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders
2018 Standout
Adipokines and the blood-brain barrier
2007
Effects of Interferon-Alpha on Rhesus Monkeys: A Nonhuman Primate Model of Cytokine-Induced Depression
2007
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
2013 Standout
Cytokines sing the blues: inflammation and the pathogenesis of depression
2005 Standout
Glutamate neurotoxicity and diseases of the nervous system
1988 Standout
Cigarette smoke and related risk factors in neurological disorders: An update
2016
Pericytes: Developmental, Physiological, and Pathological Perspectives, Problems, and Promises
2011 Standout
Carbonic anhydrase inhibitors. Sulfonamide diuretics revisited—old leads for new applications?
2008
Development, maintenance and disruption of the blood-brain barrier
2013 Standout
Cytokines as mediators of depression: What can we learn from animal studies?
2005
Dopaminergic Mechanisms of Reduced Basal Ganglia Responses to Hedonic Reward During Interferon Alfa Administration
2012
A Neurocomputational Account of How Inflammation Enhances Sensitivity to Punishments Versus Rewards
2015
Eating ourselves to death (and despair): The contribution of adiposity and inflammation to depression
2010
Potential use of tight junction modulators to reversibly open membranous barriers and improve drug delivery
2008
Effects of second generation of histamine H1 antagonists, cetirizine and ebastine, on the antitussive and rewarding effects of dihydrocodeine in mice
2003
A Molecular Functional Study on the Interactions of Drugs with Plasma Proteins
2005
How do immune cells overcome the blood–brain barrier in multiple sclerosis?
2011
Breaking boundaries—coagulation and fibrinolysis at the neurovascular interface
2015
Serotonin, tryptophan metabolism and the brain-gut-microbiome axis
2014 Standout
Cancer-related fatigue—mechanisms, risk factors, and treatments
2014 Standout
<p>Reactive Oxygen Species: Drivers of Physiological and Pathological Processes</p>
2020 Standout
Neurological complications in renal failure: a review
2004
Amyotrophic lateral sclerosis: A neurovascular disease
2011
Looking at the blood–brain barrier: Molecular anatomy and possible investigation approaches
2010
Neurological complications after orthotopic liver transplantation
2007
From inflammation to sickness and depression: when the immune system subjugates the brain
2007 Standout
Timing and Specificity of the Cognitive Changes Induced by Interleukin-2 and Interferon-α Treatments in Cancer Patients
2001
The physiology of brain histamine
2001
Organophosphorus poisoning and anaesthesia
1999
The molecular neurobiology of depression
2008 StandoutNature
Role of reactive oxygen and nitrogen species in the vascular responses to inflammation
2011
Cytokine, Sickness Behavior, and Depression
2006
Role of Microglia in Neurological Disorders and Their Potentials as a Therapeutic Target
2016
Pharmacological Properties and Molecular Mechanisms of Thymol: Prospects for Its Therapeutic Potential and Pharmaceutical Development
2017 Standout
Polypharmacy and falls in older people: Balancing evidence-based medicine against falls risk
2014
Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders
2011 Standout
The role of inflammation in depression: from evolutionary imperative to modern treatment target
2015 Standout
Nanozymes: Classification, Catalytic Mechanisms, Activity Regulation, and Applications
2019 Standout
Carbonic Anhydrase Inhibitors. Comparison of Chlorthalidone and Indapamide X-ray Crystal Structures in Adducts with Isozyme II: When Three Water Molecules and the Keto−Enol Tautomerism Make the Difference
2008
Electrosprayed nanoparticles and electrospun nanofibers based on natural materials: applications in tissue regeneration, drug delivery and pharmaceuticals
2014 Standout
Early Depressive Symptoms in Cancer Patients Receiving Interleukin 2 and/or Interferon Alfa-2b Therapy
2000
Inflammatory Biomarkers and Fatigue during Radiation Therapy for Breast and Prostate Cancer
2009
Anterior Cingulate Activation and Error Processing During Interferon-Alpha Treatment
2005
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Claudins and the Modulation of Tight Junction Permeability
2013 Standout
An immnosuppressive drug, cyclosporine-A acts like anti-depressant for rats under unpredictable chronic stress.
2003
Practical Aspects of the Ligand-Binding and Enzymatic Properties of Human Serum Albumin.
2002
Macrophage plasticity, polarization, and function in health and disease
2018 Standout
Multiple Binding Modes of Inhibitors to Carbonic Anhydrases: How to Design Specific Drugs Targeting 15 Different Isoforms?
2012 Standout
Works of Hideki Shuto being referenced
Enhancement of serotonergic neural activity contributes to cyclosporine-induced tremors in mice
1998
Oncostatin M induces functional and structural impairment of blood–brain barriers comprised of rat brain capillary endothelial cells
2008
Lipopolysaccharide-Activated Microglia Induce Dysfunction of the Blood–Brain Barrier in Rat Microvascular Endothelial Cells Co-Cultured with Microglia
2009
Repeated interferon-α administration inhibits dopaminergic neural activity in the mouse brain
1997
Tumor Necrosis Factor-α Mediates the Blood–Brain Barrier Dysfunction Induced by Activated Microglia in Mouse Brain Microvascular Endothelial Cells
2010
Cyclosporine enhances α1-adrenoceptor-mediated nitric oxide production in C6 glioma cells
2000
Protein Binding and the Metabolism of Thiamylal Enantiomers In Vitro
2000
Protective Action of Indapamide, a Thiazide-Like Diuretic, on Ischemia-Induced Injury and Barrier Dysfunction in Mouse Brain Microvascular Endothelial Cells
2007
Inhibition of GABA system involved in cyclosporine-induced convulsions
1999
Inhibition of neuronal dopamine uptake by some antiallergic drugs
1998
Inhibition of Transforming Growth Factor-β Production in Brain Pericytes Contributes to Cyclosporin A-Induced Dysfunction of the Blood-Brain Barrier
2006
Autocrine and paracrine up-regulation of blood–brain barrier function by plasminogen activator inhibitor-1
2010
An Inhibitory Role of Nitric Oxide in the Dynamic Regulation of the Blood-Brain Barrier Function
2007
Medication use as a risk factor for inpatient falls in an acute care hospital: a case‐crossover study
2010
Adverse Effect of Cyclosporin A on Barrier Functions of Cerebral Microvascular Endothelial Cells After Hypoxia-reoxygenation Damage In Vitro
2007
Protein Binding and the Metabolism of Thiamylal Enantiomers In Vitro
2000
Application of high-performance thin-layer chromatography for the detection of organophosphorus insecticides in human serum after acute poisoning
1997